Correction: Gajurel et al. Production and Secretion of Isowighteone in Hairy Root Cultures of Pigeon Pea (Cajanus cajan) Co-Treated with Multiple Elicitors. Plants 2022, 11, 834

In the original publication [...].

In the original publication [1], there was a mistake in the Title, Table 1, Figure 3, Figure 5, Table 2, and Figure 6, as published. The name of the compound cajaninstilbene acid was not correct and has been replaced with isowighteone. This error resulted from the misidentification of isowighteone as cajaninstilbene acid in previous publications.
The corrected article title should be "Production and Secretion of Isowighteone in Hairy Root Cultures of Pigeon Pea (Cajanus cajan) Co-Treated with Multiple Elicitors".
The corrected Table 1, Figure 3, Figure 5, Table 2, and Figure 6 appear below.    Yields are expressed in mg/L. Each bar represents the average of three biological replicates. Error bar represents standard deviation. Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparisons test. The lower-case letters above the column represent significant (between different letters) or non-significant (between the same letter) statistical differences. (Significance level between a and b, p < 0.05).    The compound isowighteone was misidentified as cajaninstilbene acid due to an error in previous literature. Thus, the literature review related to cajaninstilbene acid has been replaced with literature related to isowighteone: Pigeon pea (Cajanus cajan (L.) Millsp.) is an important perennial legume crop with high medicinal and nutritional values. Extracts from pigeon pea leaves are rich in different flavonoids and stilbenoids, which exhibit multiple therapeutic effects on inflammation, diabetes, dysentery, hepatitis, diarrhea, measles, and various other illnesses [1][2][3]. Several flavonoids have been reported from the extracts of pigeon pea, including apigenin, luteolin, isorhamnetin, vitexin, isovitexin, orientin, pinostrobin, isowighteone, and quercetin [4-6]. Among these flavonoids, isowighteone (3′-isoprenyl genistein) has only been reported from the seedlings of pigeon pea treated with fungi and silver nitrate solutions previously [5,6]. Isowighteone has shown antibacterial activity against Grampositive bacteria, including Listeria monocytogenes, methicillin-resistant Staphylococcus aureus, and methicillin-sensitive Staphylococcus aureus, and against Gram-negative bacteria, including Escherichia coli [7,8]. Additionally, isowighteone has shown higher cytotoxicity against human colon carcinomas, potential pro-apoptotic properties, and anti-inflammatory activities [9,10]. The compound isowighteone was misidentified as cajaninstilbene acid due to an error in previous literature. Thus, the literature review related to cajaninstilbene acid has been removed or replaced with literature related to isowighteone. With this correction, the order of some references has been adjusted accordingly.
We also would like to change the first paragraph of Section 1. Introduction from: Pigeon pea (Cajanus cajan (L.) Millsp.) is an important perennial legume crop with high medicinal and nutritional values. Extracts from pigeon pea leaves are rich in different flavonoids and stilbenoids which exhibit multiple therapeutic effects on inflammation, diabetes, dysentery, hepatitis, diarrhea, measles, and various other illnesses [1][2][3]. Among plant phenolics, the prenylated stilbenoid derivative cajaninstilbene acid (CSA) is one of the major bioactive metabolites in pigeon pea [4]. Specifically, CSA exhibits a neuroprotective function in vivo by activating the AMPK/Nrf2 pathway to reduce mitochondrial dysfunction [5]. CSA has also shown antibacterial activity against gram-positive bacteria including vancomycin-resistant Enterococcus, Staphylococcus aureus, and Bacillus subtilis, and antibiofilm activity against gram-negative bacteria including Pseudomonas aeruginosa [6][7][8]. In addition, CSA has demonstrated anti-inflammatory activity both in vivo and in vitro by inhibiting NF-κB and MAPK pathways [9]. Furthermore, studies suggest that CSA shows therapeutic potential in the treatment of both osteoporosis and the early stages of Alzheimer's disease, with it also demonstrating antidepressant-like effects in mice models [10-12] and higher antioxidant activity than the stilbenoid resveratrol in cell-free systems [13]. The diverse biological properties of CSA support its potential application as a nutraceutical for human health benefits.
Moreover, the name of the compound cajaninstilbene acid in the whole text has been replaced with isowighteone. Correction has also been made to the Supplementary Materials.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.